Overview

Ascending Dose Study to Investigate the Safety, Tolerability and Pharmacokinetics of BAY1128688 After Multiple Oral Administrations in Healthy Women

Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The objective of this trial is to investigate the safety and tolerability of BAY1128688 and to determine the concentration of this substance in blood after repeated administration by the oral route. The investigational substance will be administered in tablet form to healthy women.
Phase:
Phase 1
Details
Lead Sponsor:
Bayer